These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 3489314)
21. gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms. Edwards SA; Fan H J Virol; 1979 May; 30(2):551-63. PubMed ID: 469993 [TBL] [Abstract][Full Text] [Related]
22. Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing. Felsenstein KM; Goff SP J Virol; 1988 Jun; 62(6):2179-82. PubMed ID: 2452901 [TBL] [Abstract][Full Text] [Related]
24. Further characterization of the in vitro products generated by proteolytic cleavage of Gazdar murine sarcoma virus p65gag. Maxwell SA; Arlinghaus RB J Gen Virol; 1985 Jan; 66 ( Pt 1)():97-107. PubMed ID: 2981963 [TBL] [Abstract][Full Text] [Related]
25. Evidence for attachment of fatty acid to varicella-zoster virus glycoproteins and effect of cerulenin on the maturation of varicella-zoster virus glycoproteins. Namazue J; Kato T; Okuno T; Shiraki K; Yamanishi K Intervirology; 1989; 30(5):268-77. PubMed ID: 2551842 [TBL] [Abstract][Full Text] [Related]
26. Assembly and composition of intracellular particles formed by Moloney murine leukemia virus. Hansen M; Jelinek L; Jones RS; Stegeman-Olsen J; Barklis E J Virol; 1993 Sep; 67(9):5163-74. PubMed ID: 8350394 [TBL] [Abstract][Full Text] [Related]
27. Transport and assembly of gag proteins into Moloney murine leukemia virus. Hansen M; Jelinek L; Whiting S; Barklis E J Virol; 1990 Nov; 64(11):5306-16. PubMed ID: 1698996 [TBL] [Abstract][Full Text] [Related]
28. Role of cell cytoskeleton in Mo-MuLV env transport and processing: implications in ts1 neuropathology. Soong MM; Tompkins WA Exp Mol Pathol; 1987 Jun; 46(3):294-311. PubMed ID: 2439368 [TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of a Mo-MuSV-transformed TB cell line that produces noninfectious MuSV particles with uncleaved gag protein which is processed in the presence of Mo-MuLV. Soong MM; Yuen PH; Wong PK Virology; 1984 Jan; 132(2):390-400. PubMed ID: 6322421 [TBL] [Abstract][Full Text] [Related]
30. Structure of glycosylated and unglycosylated gag and gag-pol precursor proteins of Moloney murine leukemia virus. Saris CJ; van Eenbergen J; Liskamp RM; Bloemers HP J Virol; 1983 Jun; 46(3):841-59. PubMed ID: 6602220 [TBL] [Abstract][Full Text] [Related]
31. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239 [TBL] [Abstract][Full Text] [Related]
32. Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene. Schultz AM; Rabin EH; Oroszlan S J Virol; 1979 Apr; 30(1):255-66. PubMed ID: 480454 [TBL] [Abstract][Full Text] [Related]
33. Cleavage of Rauscher leukaemia virus (R-MuLV) Pr65gag by the Moloney leukaemia virus (M-MuLV) proteolytic activity produces the R-MuLV-specific but not the M-MuLV-specific 40 000 dalton intermediate polypeptide. Yoshinaka Y; Luftig RB J Gen Virol; 1981 May; 54(Pt 1):33-8. PubMed ID: 7288407 [TBL] [Abstract][Full Text] [Related]
34. An insertion mutation in the pol gene of Moloney murine leukemia virus results in temperature-sensitive pol maturation and viral replication. Tanese N; Roth M; Epstein H; Goff SP Virology; 1989 Jun; 170(2):378-84. PubMed ID: 2786280 [TBL] [Abstract][Full Text] [Related]
35. Characterization of a virus-specific proteolytic activity processing the gag precursor of the simian sarcoma-associated virus. Kräusslich HG; Von der Helm K Virology; 1987 Feb; 156(2):246-52. PubMed ID: 3027976 [TBL] [Abstract][Full Text] [Related]
36. Further studies on the glycosylated gag gene products of Rauscher murine leukemia virus: identification of an N-terminal 45,000-dalton cleavage product. Naso RB; Stanker LH; Kopchick JJ; Ng VL; Karshin WL; Arlinghaus RB J Virol; 1983 Mar; 45(3):1200-6. PubMed ID: 6601196 [TBL] [Abstract][Full Text] [Related]
37. In vitro inhibition of HIV-1 proteinase by cerulenin. Moelling K; Schulze T; Knoop MT; Kay J; Jupp R; Nicolaou G; Pearl LH FEBS Lett; 1990 Feb; 261(2):373-7. PubMed ID: 1690152 [TBL] [Abstract][Full Text] [Related]
38. Mutations at the capsid-nucleocapsid cleavage site of gag polyprotein of Moloney murine leukemia virus abolish virus infectivity. Housset V; Darlix JL C R Acad Sci III; 1996 Feb; 319(2):81-9. PubMed ID: 8680959 [TBL] [Abstract][Full Text] [Related]
39. Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding. Suomalainen M; Hultenby K; Garoff H J Cell Biol; 1996 Dec; 135(6 Pt 2):1841-52. PubMed ID: 8991095 [TBL] [Abstract][Full Text] [Related]
40. A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells. Nash MA; Meyer MK; Decker GL; Arlinghaus RB J Virol; 1993 Mar; 67(3):1350-6. PubMed ID: 8437220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]